Pimobendan 74150-27-9 Metabolism PDE inhibitor
Ụgwọ:T/T, L/C
Isi mmalite ngwaahịa:China
Ọdụ ụgbọ mmiri:Beijing/Shanghai/Hangzhou
Nye iwu (MOQ):1g
Etiti oge:3 ụbọchị ọrụ
Ike mmepụta:1kg / ọnwa
Ọnọdụ nchekwa:Echekwara ya na ebe dị jụụ, ebe akọrọ, okpomọkụ ụlọ.
Ihe ngwugwu:vial, karama
Nha ngwugwu:1g / vial, 5/vial, 10g / vial, 50g / karama, 500g / karama
Ozi nchekwa:UN 2811 6.1/PG 3
Okwu mmalite
Pimobendan, bụ ọgwụ anụmanụ.Ọ bụ ihe mmetụta calcium na onye na-emechi phosphodiesterase 3 (PDE3) nwere mmetụta inotropic na vasodilator dị mma.
A na-eji Pimobendan na njikwa nkụda obi na nkịta, nke na-ebutekarị ọrịa myxomatous mitral valve (nke a na-akpọbu endocardiosis), ma ọ bụ cardiomyopathy dilated.Nnyocha egosila na dị ka monotherapy, pimobendan na-abawanye oge ịlanarị ma na-eme ka ndụ dịkwuo mma na ndị ọrịa canine nwere nkụchi obi nke abụọ na ọrịa mitral valvụ ma e jiri ya tụnyere benazepril, onye na-egbochi ACE.
Nkọwapụta (USP43)
| Ihe | Nkọwapụta |
| Ọdịdị | White ma ọ bụ ubé odo ntụ ntụ, hygroscopic |
| Mp | Ihe dịka 242 ℃ |
| Solubility | Ihe na-adịghị ahụkebe n'ime mmiri, na-agbaze kpamkpam na dimethylformamide, soluble ntakịrị na acetone yana na methanil. |
| njirimara | Infrared absorption spectrophotometry, atụnyere pimobendan CRS. |
| Oge njide nke isi kacha elu nke ngwọta Sample dabara na nke Standard ngwaahịa ngwọta, dị ka enwetara na Organic adịghị ọcha ule. | |
| Ọla dị arọ | ≤10ppm |
| Ọkpụkpụ granularity | P90 ≤ 25μm |
| Nha urughuru | 20-80 ntupu |
| Ihe mgbaze fọdụrụnụ | ≤500ppm |
| Mmiri | ≤ 1.0% |
| Nyocha | 98.0% ~ 102.0% |
| Sulfated uyi | ≤0.10% |
| Ihe ndị emetụtara (HPLC) | |
| adịghị ọcha A | ≤0.10% |
| adịghị ọcha B | ≤0.10% |
| Ọdịghị ọcha ọ bụla ọzọ | ≤0.10% |
| Mkpokọta adịghị ọcha | ≤0.20% |
